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Aim: Recent analyses suggest the decline in coronary heart 
disease (CHD) mortality rates is slowing in younger age groups 
in countries such as the UK and US. We aimed to assess recent 
mortality rate trends in all circulatory disease and its subtypes  
in Australia.
Methods: Annual all circulatory, CHD, and cerebrovascular 
disease mortality rates between 1980 and 2005 for Australia were 
analysed. Data were stratified by sex and ten-year age group (age 
35 to 85+). The annual rate of change and significant changes in 
trends were identified using joinpoint Poisson regression. 
Results: Age standardised all circulatory disease mortality rates 
continue to decline in Australia, falling from 441 per 100,000 in 
1980 to 145 per 100,000 in 2005 for males and from 264 per 
100,000 to 96 per 100,000 for females. The rate of decline from 
both CHD and cerebrovascular disease appears to be stable or 
accelerating for individuals aged 55 years and over. However,  
the decline in young men and women aged 35-54 years is 
slowing for CHD and cerebrovascular disease mortality alike 
(except cerebrovascular disease mortality in males aged 35-44). 
For females aged 35-44 and 45-54 there has been no change in 
the cerebrovascular mortality rate since 1993 and 1999, 
respectively. 
Conclusions: In Australia, whilst in older adults the decline  
in cardiovascular mortality rates is generally accelerating, in 
younger adults it appears to be slowing. It will be important  
to identify the causes of these trends.
Introduction
Age-standardised cardiovascular disease (CVD) mortality rates 
have been continually declining since the 1960s in the developed 
world1. Between 1990 and 1997 it appeared that there was a 
slowing of the decline in age-standardised cerebrovascular and 
coronary heart disease (CHD) mortality rates in the US.1 
However, more recent analyses suggest the decline in age-
standardised CHD mortality rates has continued in countries 
such as the US and UK since 1997, and has actually accelerated 
in recent years.2, 3 
In younger adults these trends appear to differ. Recent data 
suggests a slowing of the decline in CHD mortality rates at 
younger ages in several developed countries (2–5). Specifically, 
there has been a slowing in the decline of CHD mortality rates 
in individuals aged under 55 years in the UK and US (2, 4). In 
Wales this is most pronounced in the most deprived population 
sub-group where CHD mortality rates have stopped decreasing 
at all for the first time in over two decades.3 
To date there have been no age-specific analyses of trends in 
CVD mortality rates within Australia. Here we analysed trends 
in age-specific CVD mortality rates, and its major subtypes – 
CHD and cerebrovascular disease – in Australia between 1980 
and 2005. 
Methods 
Data 
National mortality rates were obtained for ten year age groups 
from age 35 to 84 years between 1980 and 2005 for all 
circulatory disease (ICD-9 codes 390-459 & ICD-10 codes 
I00-99), CHD (ICD-9 codes 410-414) and cerebrovascular 
disease (ICD-9 codes 430-438 & ICD-10 codes I60-I69). 
Number of deaths and population counts obtained for Australia 
(source: Australian Institute of Health and Welfare) were used  
to calculate annual mortality rates. Within each 10 year age 
group the number of deaths in each year was divided by the 
mid-year population to calculate the age-specific mortality rate 
for that year. Age-standardised mortality rates were calculated 
for all circulatory disease mortality based on the World  
Health Organisation World Standard Population (New),  
for comparability with other international analyses. Direct 
standardisation was used. For males and females separately,  
the corresponding age-specific estimated mortality rates for all 
circulatory causes of death (for each 5 year age group from 0–4 
to 85+, calculated as above) were applied to the World Standard 
Population.6 
Joinpoint Poisson regression provided the estimated annual 
percentage change (EAPC) in each mortality rate and detected 
points in time at which significant changes in the trends 
occurred (Joinpoint Regression Program, Version 3.4.2. October 
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2009; Statistical Research and Applications Branch, National 
Cancer Institute). Joinpoint regression is a statistical method 
which identifies points (joinpoints) where the direction or the 
magnitude of the trend significantly changes. The analysis starts 
with a minimal number of joinpoints (eg 0 joinpoints, which 
represents a straight line) and tests whether one or more 
joinpoints (here up to a maximum of 3) are significant and need 
to be added to the model. In the final model every joinpoint 
represents a significant change in the slope of the trend.  
A regression line is fitted to the natural logarithm of the rates  
to calculate the EAPC. The joinpoint permutation test was used 
to select the most parsimonious model that best fitted the data.  
A maximum of three joinpoints was allowed for estimations.  
For each annual percentage change estimate, the corresponding 
95% confidence interval (95% CI) was calculated.7 
Results 
The age-standardised rate of all circulatory disease mortality  
has declined since 1980 in Australia (Figure 1), from 441 per 
100,000 to 145 per 100,000 in 2005 for males and from 264  
per 100,000 to 96 per 100,000 in 2005 for females.
Figure	1:	Age	standardised	all	circulatory	disease	
mortality	rates	(standardised	to	the	World	Health	
Organisation World Standard).
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Age-specific all circulatory disease mortality rates declined 
between 1980 and 2005 for men and women aged 55 years and 
over, with the rate of decline generally accelerating in the most 
recent period (data not shown – Supplementary Table available). 
In both males and females aged 35–44 and 45–54, circulatory 
disease mortality rates declined continuously until the early 
1990s, after which the rate of decline slowed. 
Similarly, age-specific rates of CHD and cerebrovascular disease 
decreased in all age groups in both males and females between 
1980 and 2005 (Figure 2). Reductions in CHD mortality rates 
ranged from 3150 per 100,000 in 1980 to 1079 per 100,000 in 
2005 for males aged 75–84 to 42 per 100,000 in 1980 to 16 per 
100,000 in 2005 for males aged 35–44 years. For females, the 
reduction in CHD mortality rates ranged from 1824 per 
100,000 in 1980 to 643 per 100,000 in 2005 for 75–84 year 
olds to 11 per 100,000 in 1980 to 4 per 100,000 in 2005 for 
females aged 35–44 years. Joinpoint analysis of CHD mortality 
rates demonstrated that for males and females aged 55–64, 
65–74 and 75–84 the CHD mortality rate decline accelerated 
from the late 1980s/ early 1990s.  In contrast, for male and 
female 35–44 and 45–54 year olds the most recent change in 
rate was a deceleration in the decline (Table 1a, Figure 2a). 
Figure	2:	Trends	in	age-specific	(A)	coronary	heart	disease	
mortality	rates	and	(B)	cerebrovascular	disease	mortality	
rates	for	each	10	year	age	group	between	1980	and	2005
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Decreases in cerebrovascular disease mortality rates ranged from 
1298 per 100,000 in 1980 to 465 per 100,000 in 2005 for males 
aged 75–84 years to 8 per 100,000 in 1980 to 3 per 100,000 in 
2005 for males aged 35–44 years. For females, the reduction in 
cerebrovascular mortality rates ranged from 1222 per 100,000 in 
1980 to 391 per 100,000 in 2005 for 75–84 year olds to 9 per 
100,000 in 1980 to 4 per 100,000 in 2005 for females aged 
35–44 years. Joinpoint analysis of cerebrovascular disease 
mortality rates demonstrated that a slowing in the 
cerebrovascular mortality rate decline in females aged 35–44  
and 45–54 years and males aged 45–54 years occurred in the 
most recent period (Table 1b, Figure 2b). 
For females aged 35–44 and 45–54, this slowing has led to a 
plateau in the cerebrovascular mortality rate, with  no significant 
change in cerebrovascular mortality rates since 1993 and 1999, 
respectively. For males aged 35–44 the annual rate of change for 
cerebrovascular mortality was a constant -3.6% between 1980 
and 2005. No significant change in the trend for cerebrovascular 
disease mortality rates was detected for males aged 55–64 years 
and females aged 55–64 and 65–74 years throughout the entire 
analysis period. A plateau in the mortality rate declines in the 
early 1990s prior to further acceleration in the most recent 
periods was observed for males aged 65–74 and 75–84years and 
females aged 75–84 years.
Discussion 
This detailed analysis of CVD mortality rates between 1980 and 
2005 demonstrates that within Australia, individuals aged over 
55 years showed either continued or accelerated declines in CHD 
and cerebrovascular disease mortality rates in both sexes in most 
recent times. A slowing in the rate of decline of CHD was the 
most recent change observed in males and females aged between 
35 and 54 years. Trends in cerebrovascular disease mortality 
were similar, but more variable. For males aged 45–54 years and 
females aged 35–54 years a slowing in the rate of decline was 
observed in the most recent time period, resulting in a non-
significant change in the cerebrovascular disease mortality rates 
for females since the 1990s. 
The continuing or accelerating decline in CHD and 
cerebrovascular disease mortality rates estimated in Australian 
adults aged 55 years and older is consistent with trends in other 
developed nations.2, 3 Improvements in population risk factors8 
and a more widespread uptake of  effective therapies9 are the 
likely explanations for this continued decline.10, 11 
A recent slowing in the rate of CHD mortality improvement in 
individuals less than 55 years of age has been reported for the 
US, UK, and Scotland.2-4 Furthermore, a prior analysis of age 
and cohort specific CHD mortality rates in Australia suggested  
a slowing prior to 1992 for males born between 1955 and 1964.12 
 
 
 Period I Period II Period III Period IV
Age group Years EAPC Years EAPC Years EAPC Years EAPC
males 35-44 1980-1994 -5.1 (-5.8,-4.3) 1994-2005 -2.2 (-3.4,-0.9)
45-54 1980-1994 -7.1 (-7.4,-6.7) 1994-2005 -4.0 (-4.6,-3.3)
55-64 1980-1987 -4.1 (-4.8,-3.5) 1987-2005 -6.9 (-7.1,-6.7)
65-74 1980-1988 -3.8 (-4.4,-3.2) 1988-1997 -5.3 (-6.0,-4.6) 1997-2005 -8.3 (-9.2,-7.4)
75-84 1980-1994 -2.4 (-2.7,-2.1) 1994-2005 -6.4 (-6.9,-5.9)
females
 
35-44 1980-1988 -9.9 (-12.2,-7.7) 1988-2005 -1.3 (-2.2,-0.4)
45-54 1980-1996 -8.0 (-8.7,-7.2) 1996-2005 -3.3 (-5.6,-1.0)
55-64 1980-1992 -5.2 (-5.7,-4.6) 1992-2005 -8.8 (-9.5,-8.1)
65-74 1980-1985 -1.6 (-2.5,-0.7) 1985-1990 -4.7 (-5.9,-3.4) 1990-2000 -6.8 (-7.2,-6.4) 2000-2005 -11.2 (-12.5,-9.8)
75-84 1980-1987 -1.0 (-2.1,0.0) 1987-1994 -3.0 (-4.2,-1.8) 1994-2005 -6.6 (-7.2,-6.1)  
 Period I Period II Period III Period IV
age group  Years EAPC Years EAPC Years rate change Years EAPC
males 35-44 1980-2005 -3.6 (-4.2,-3.1)
45-54 1980-1988 -8.7 (-11.2,-6.1) 1988-2005 -4.3 (-5.4,-3.2)
55-64 1980-2005 -6.1 (-6.3,-5.8)
65-74 1980-1991 -5.7 (-6.3,-5.2) 1991-1996 -3.1 (-5.9,-0.2) 1996-2005 -6.6 (-7.6,-5.7)
75-84 1980-1991 -4.7 (-5.3,-4.1) 1991-1994 -0.5 (-9.7,9.6) 1994-2005 -5.1 (-5.8,-4.5)
females
 
35-44 1980-1993 -7.2 (-9.3,-5.1) 1993-2005 -0.1 (-2.9,2.8)
45-54 1980-1986 -9.2 (-11.7,-6.6) 1986-1999 -5.7 (-6.9,-4.5) 1999-2005 -1.7 (-5.3,2.1)
55-64 1980-2005 -6.7 (-7.0,-6.4)
65-74 1980-2005 -5.3 (-5.6,-5.0)
75-84 1980-1991 -4.7 (-5.3,-4.1) 1991-1994 -0.5 (-9.7,9.6) 1994-2005 -5.1 (-5.8,-4.5)   
Table	1a:	Annual	change	in	rate	(95%	CI)	of	(A)	coronary	heart	disease,	and	(B)	cerebrovascular	disease	mortality	 
between	1980	and	2005.	The	annual	change	in	rate	in	each	period	is	significantly	different	from	the	preceding	period,	 
as	determined	by	joinpoint	analysis.
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Here, we confirm this suggestion and also report similar findings 
for females and cerebrovascular disease. Follow-up of this data 
beyond 2005 will be necessary to understand whether these 
observations are age-group or birth-cohort specific. 
In the current analysis, the year in which the slowing of the 
decline in CHD mortality rates commenced in Australia is 
estimated to occur between 1988 and 1996. This is similar to the 
US, in which the deceleration was shown to commence in 1989, 
with further deceleration observed in 2000.2 In the UK and 
Scotland the decelerations commenced slightly later, between 
1994 and 2003.3, 4 The window for the commencement of the 
decline in cerebrovascular mortality rates in Australia was 
estimated to occur during a similar time frame as was observed 
for CHD, ranging between 1988 and 1999. A slowing in the 
cerebrovascular mortality rate decline in the late 1980s/ early 
1990s was demonstrated for all age groups, both in the current 
study and previously, for a number of countries including the  
US and Australia.1, 13-15 The current study demonstrates that in 
Australia the observed slowing of the rate of decline of 
cerebrovascular disease mortality rates in the early 1990s was 
followed by an increase in the rate of decline since the mid-1990s 
for those aged over 55 years. Similarly, recent analysis of 
age-adjusted cerebrovascular death rates in the US revealed a 
continuation of decline at the beginning of the 21st century.16
Potential causes of the estimated slowing of the rate of decline  
of CHD and cerebrovascular disease mortality rates in younger 
adults include artefact (such as coding changes), the reaching of  
a natural low rate that cannot be improved upon, the worsening 
or lack of further improvement in risk factors, and absence of 
further decreases in case-fatality rates related to treatment. It is 
possible that changes in coding of cause of death, either due to 
physician coding practice or the change from ICD-9 to ICD-10 
(which occurred in Australia in 1998) had a role in the observed 
trends. The change from ICD-9 to ICD-10 is estimated to lead 
to a slight increase in coding of deaths due to cerebrovascular 
disease and a slight decrease in coding of deaths to diseases of the 
heart17. However, as we observed similar trends for all circulatory 
disease (which as an overarching category is less likely to 
experience coding changes) and for both CHD and 
cerebrovascular disease, we believe that this role is unlikely to  
be large. In addition, the slowing in the rate decline observed in 
those under 55 occurred in all cases prior to 1998. A nadir is also 
unlikely. This is because different countries have demonstrated  
a plateau at different absolute rates and because some analyses 
have shown an increase in mortality rate.3 For example, for males 
aged 45–54, a plateau in the CHD mortality rate was seen at 
approximately 50 per 100,000 in Australia but 100 per 100,000 
in the USA.2 It appears most likely that the slowing of the 
mortality rate decline observed in individuals under 55 years is  
a result of changes in risk factors or treatment trends. A slowing 
in the decline could equally be caused by a worsening of risk 
factors (such as obesity and hypertension), or by diminishing 
returns from previously successful interventions (such as 
smoking cessation or hypertension control). The increased 
prevalence of obesity and diabetes has been estimated to increase 
the numbers of CHD deaths over time,18 and others have also 
predicted that the increasing prevalence of obesity and diabetes 
will exert a greater impact on CVD mortality rates.19 
A key limitation of the current study is that the analysis of 
population mortality rate trends does not indicate to what  
extent the trends are a result of changes in incidence or changes 
in case-fatality. It will be important to investigate this further  
if we are to gain a more in-depth understanding of the 
underlying cause of the decline in trends.  
It is essential that we expound the underlying causes of the 
slowing of the CVD mortality rate decline in young adults.  
The escalating prevalence of obesity and diabetes is projected  
to continue in future years.20, 21 If these conditions are indeed 
contributing to the slowing of the decline of CVD mortality 
rates, then we may expect further worldwide increases in CVD 
mortality rates. Moreover, as the existing cohort of young adults 
age, current declines in CVD mortality amongst the elderly  
may be diminished. 
In conclusion, the decline in CHD and cerebrovascular disease 
mortality rates is slowing in Australian males and females aged 
under 55 years. These results are similar to that observed for 
CHD in the US and UK. Understanding the causes of these 
trends will be essential to predict whether the slowing of the 
CVD mortality rate decline is likely to continue in young  
adults, and even to extend to older age groups. 
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Department of Error 
The figures in peer reviewed article ‘Age-specific 
trends in cardiovascular mortality rates in Australia 
between 1980 and 2005’ by Kathryn Backholer et 
al, published in Australasian Epidemiologists  in 
2011, Volume 18(1), on page 34, had the age labels 
back-to-front. Here are the correct figures. 
Apologies from the team. 
Dr Xiang-Yu (Janet) Hou
AE Editor 
Figure 1: Age standardised all circulatory disease mortality rates 
(standardised to the World Health Organisation World Standard).
Figure 2: Trends in age-specific (A) coronary heart disease 
mortality rates and (B) cerebrovascular disease mortality 
rates for each 10 year age group between 1980 and 2005
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